Indraprastha Medical Corporation Limited (NSE: INDRAMEDCO), ISIN INE681B01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDRAMEDCO last traded at ₹363.35 (-1.33%), with a 52-week range of ₹342.35 to ₹640.05 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 51.00%, FIIs 2.77%, DIIs 0.59%, mutual funds 0.01%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.